Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 25, 2015 7:24 AM ET

Pharmaceuticals

Company Overview of Optimer Pharmaceuticals, Inc.

Executive Profile

Stephen W. Webster

Chief Financial Officer, Spark Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 7 different industries.

See Board Relationships
53$694,383
As of Fiscal Year 2014

Background

Mr. Stephen W. Webster has been the Chief Financial Officer at Spark Therapeutics Inc. since July 2014 and served as the Chief Financial Officer and Senior Vice President of Optimer Pharmaceuticals, Inc. since June 5, 2012 until 2013 and served as its Principal Accounting Officer and Senior Vice President of Finance. Mr. Webster serves as Managing Director of Gleacher & Company Securities, Inc. Mr. Webster served as Managing Director of First Albany Corporation since ...

Corporate Headquarters

101 Hudson Street
Jersey City, New Jersey 07302

United States

Phone: 201-333-8819
Fax: 201-333-8870

Board Members Memberships

Former Chief Executive Officer, President and Director
Director
Director
2008-N/A
Independent Director, Member of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
2014-Present
Non-Employee Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee

Education

BA
Dartmouth College
MBA
University of Pennsylvania - The Wharton School

Other Affiliations

Annual Compensation

Salary$147,528
Total Annual Compensation$147,528

Stocks Options

Restricted Stock Awards$481,494
All Other Compensation$12,861
Unexercisable Options$186,015
Total Number of Options$186,015

Total Compensation

Total Annual Cash Compensation$212,889
Total Short Term Compensation$147,528
Other Long Term Compensation$494,355
Total Calculated Compensation$694,383
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Optimer Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.